Viking Line Abp BUSINESS REVIEW 24.4.2025, 9.00 AM A quarter characterized by ship dockings and a challenging market environmentJANUARY-MARCH 2025 (compared ...

Chris Hemsworth's Thor portrayal in the Marvel Cinematic Universe gets bashed for hurting the Norse mythology and culture.

Discover why VKTX's deep selloff offers a compelling opportunity with improved safety margins, promising GLP-1 candidates, ...

The mythical creature, which started as the symbol for the Boston Athletic Association, has become synonymous with the historic race, gracing runners’ jackets, medals, and trophies.

Viking Therapeutics (NASDAQ: VKTX) is a healthcare company that possesses a lot of growth potential. And last year, its shares rose by 116%, as investors were bullish on its prospects. This year ...

They are a symbol of strength, courage, and the untamed natural world. The dire wolf holds spiritual and ecological significance for indigenous nations like the Mandan, Hidatsa, and Arikara Nation ...

Goldman Sachs launched its coverage of Viking Therapeutics (NASDAQ:VKTX) with a Neutral recommendation and a $30 per share target on Tuesday, arguing that competitive headwinds in the weight loss ...

Nearly 30 years after it withstood the blast of a 4,000-pound bomb, the Survivor Tree—an American elm that became a symbol of resilience after the Oklahoma City bombing—continues to spread its ...

This is an exceptionally hard model to get right, even more so than short-haul alternatives. Norse continues to focus more on charters and leasing than scheduled flying, with IndiGo to have a third of ...

Tour Odin's sacred lands in this Odin: Valhalla Rising trailer for the MMORPG. The trailer shows the world tree Yggdrasil, lush landscapes of Midgard, and more. Odin: Valhalla Rising will be ...

An icon of a desk calendar. An icon of a circle with a diagonal line across. An icon of a block arrow pointing to the right. An icon of a paper envelope. An icon of the Facebook "f" mark. An icon ...

Viking Therapeutics (NASDAQ: VKTX) is operating in one of the highest-growth pharma areas around. I'm talking about the weight loss drug market -- one that Morgan Stanley analysts say may multiply ...